PALI

Palisade Bio Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 6/10
Palisade Bio sales and earnings growth
PALI Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 97.06%
  • FCF Y/Y↑ 11.04%
Palisade Bio gross and profit margin trends
PALI Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ -5594.17%
Palisade Bio net debt vs free cash flow
PALI Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1677.1

Palisade Bio stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks